STAT+: Vertex, CRISPR Therapeutics inch ahead of rival for genetic fix to sickle cell disease
The first CRISPR treatment for sickle cell disease has been submitted to the Food and…
Author: STAT
Why the early tests of ChatGPT in medicine miss the mark
ChatGPT has rocketed into health care like a medical prodigy. The artificial intelligence tool correctly…
.jpg)
STAT+: A devastating skin condition could soon get its first medication, as the frontiers of gene therapy expand
Wounds have been a constant fact of Aaron Owens’ life. His skin is so fragile…
STAT+: The biotech scorecard for the second quarter: 24 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second…
Opinion: Emergency rooms need clear guidelines about how to handle law enforcement
The patient arrived in the trauma bay with gunshot wounds to his chest and abdomen….
‘If we don’t, others will’: White House Covid adviser calls on doctors to combat a vacuum of medical information
WALTHAM, Mass. — The coordinator of the Biden administration’s Covid-19 response team called on doctors…
STAT+: Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying
WASHINGTON — The Biden administration backed off some of its plans to rein in billions…
.jpg)
STAT+: European Union drug pricing proposal for the pandemic treaty generates pushback
Amid treaty talks to create equitable access to medical products during pandemics, the European Union…
STAT+: Inflation caused a sizable drop in net drug prices in late 2022, analysis finds
Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name…
STAT+: FDA report details problems at Global Pharma plant involved in eye drop recall
Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed…
STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case
And so, another working week will soon draw to a close. Not a moment too…
Opinion: STAT+: 3 keys to successful biopharma-academia drug development collaborations
Academia can be an excellent source of novel drug targets and new technologies that can…
Genetic differences in breast tumors may contribute to racial disparities
Clinicians know the odds tend to be stacked against Black breast cancer patients. They get…
Trans health care, already under attack, faces new obstacle with end of Covid public health emergency
As states across the U.S. introduce anti-trans legislation, transgender and nonbinary people face increasing restrictions…
STAT+: Solicitor General urges Supreme Court to review ‘skinny labeling’ and generic drug access
The U.S. solicitor general urged the U.S. Supreme Court to review a controversy over so-called…
STAT+: Drug middlemen switch tactics, but the outcome is the same: high prices
WASHINGTON — Prescription drug middlemen are shifting away from rebates that have been blamed in…
Gunshot injuries surged in U.S. during pandemic, CDC says
NEW YORK — For every American killed by gunfire, an estimated two or more more…
Listen: Biotech’s monkey shortage, the broken generics market, & conference cancel culture
What happened to the market for monkeys? Are some drugs too cheap? And why are…
STAT+: FDA proposes a new plan to streamline updates to medical devices that use AI
The Food and Drug Administration on Thursday released a new plan allowing developers of medical…
Texas judge strikes down major Obamacare provision protecting birth control, PrEP coverage
WASHINGTON — A federal judge Thursday reversed a major Obamacare provision requiring plans to cover…
STAT+: Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine
Rise and shine, another busy day is on the way. We can tell because the…
STAT+: Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
Mathai Mammen, who until recently led research at Johnson & Johnson, will become the CEO…
Opinion: To deal with the next pandemic, the FDA needs an Office of Preparedness and Response
New evidence of the spillover of the avian flu virus, known as H5N1, to some…
STAT+: Is there $21 billion left for Covid response, or $5 billion? The White House is using fuzzy math
WASHINGTON — How much money does the federal government still have set aside for the…
In the whitewashed world of Alzheimer’s research, one scientist is on a quest to understand the diversity of brains
CHICAGO — When she entered the field of Alzheimer’s research a quarter century ago, Lisa…
STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost
In a rare move, the Dutch health ministry refused to provide coverage for a Gilead…
STAT+: NIH releases data showing more clinical trial sponsors are reporting results, but most miss deadlines
In response to mounting criticism, the National Institutes of Health published data that shows an…
New lupus partnership with FDA aims to end drug trials’ history of failure
Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them…
Cases of Marburg going unreported in Equatorial Guinea, WHO says
The Marburg outbreak in Equatorial Guinea continues to grow, the World Health Organization said Wednesday,…
STAT+: New research may give geneticists a long-sought tool: a targeted protein delivery device
Mark Hurst just wanted to kill some bugs. A newly credentialed bacteriologist working for the…
STAT+: British Columbia to bar Americans from buying Ozempic over supply concerns
British Columbia plans to limit sales of the popular diabetes drug Ozempic to Canadian residents…
FDA approves over-the-counter Narcan. Here’s what it means
The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing…
STAT+: Pharmalittle: WHO may add obesity drugs to essential medicines list; monkey shortage may delay drug development
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Medical device companies now need to prove to FDA they’re protected against cyber attacks
Hidden in this year’s federal spending bill, among major changes to Medicare payments to doctors…
STAT+: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
A growing shortage of monkeys used for early-stage pharmaceutical research is causing concern that many…
Pressure is building on pharma and biotech companies to take climate action
As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies…
Opinion: Why the rise of DNA testing is creating challenges — and an opportunity
Twenty years ago, virtually all people seeking genetic testing were individuals diagnosed with diseases possibly…
Republicans press Becerra on gender-affirming care, reproductive rights
WASHINGTON — Republicans hammered the health secretary in hearings Tuesday, previewing a line of health-…
Focus Covid booster campaigns on high-risk people, WHO’s vaccine experts recommend
A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday…
STAT+: Oscar Health names former Aetna executive as new CEO
The tech-forward insurer Oscar Health has tapped former Aetna CEO Mark Bertolini to be its…
STAT+: Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price negotiations
Top of the morning to you. Steely gray skies are hovering over the Pharmalot campus…
STAT+: With new study data, Intra-Cellular could expand use of approved mood-disorder treatment
Intra-Cellular Therapies, maker of an approved treatment for schizophrenia and bipolar depression, announced positive results…
STAT+: Viking Therapeutics releases early but promising weight loss data on new GLP-1 drug
Viking Therapeutics, a small biotechnology company, said Tuesday that its experimental medicine led patients to…
Opinion: Biden’s budget boosts funds for future pandemics, but cuts them for current ones
The Biden administration has rightly talked a lot about pandemic preparedness. And to its credit,…
STAT+: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
In the doctor’s offices of the future, artificial intelligence will be a fly on the…
How the drug industry uses fear of fentanyl to extract more profit from naloxone
As the U.S. drug crisis has accelerated, the pharmaceutical industry has jumped into action —…
Opinion: Rolling back SNAP benefits puts millions of children at risk of hunger and long-term health consequences
At our pediatric clinic, we recently saw a child whose mother lost her job during…
STAT+: Could a fight over cost-effectiveness upend Medicare drug price negotiation before it’s begun?
WASHINGTON — As Medicare drug price negotiation looms, congressional Republicans are scrambling to push through…
STAT+: Novartis data set up multibillion-dollar battle over breast cancer drugs
Novartis announced data Monday that could set up one of the biggest marketing battles in…
A half century after Prozac, a new generation of depression drugs is bringing hope to a long-stagnant field
This article is excerpted from the latest STAT Report: Treating Depression: a new era of…